RT @drdavidliew: This feels like an excellent starting point for Tuesday's ORAL Surveillance malignancy discussion. RWE
Tweet Content
This feels like an excellent starting point for Tuesday's ORAL Surveillance malignancy discussion.
RWE Cohort: HR 1.01 (0.83-1.22)
RCT-dup Cohort: HR 1.19 (0.86-1.64)
ORAL Surveillance: HR 1.48 (1.04-2.09)
Interesting day 4 ahead!
great talk @SeoyoungCKim #ACR21 7S413 @RheumNow https://t.co/YSau21goMr
Show on Archive Page
On
Display in Search Results
On
PDQ
Off